We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$114B
AUM Growth
+$3.58B
Cap. Flow
+$1.84B
Cap. Flow %
1.62%
Top 10 Hldgs %
9.08%
Holding
3,913
New
495
Increased
1,847
Reduced
1,145
Closed
397

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$307M
2
COST icon
Costco
COST
+$279M
3
LOW icon
Lowe's Companies
LOW
+$273M
4
MSFT icon
Microsoft
MSFT
+$230M
5
CVX icon
Chevron
CVX
+$225M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Technology 14.11%
3 Financials 10.92%
4 Consumer Discretionary 9.85%
5 Real Estate 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEHL icon
3501
Antelope Enterprise Holdings
AEHL
$5.37M
0
EVOK
3502
DELISTED
Evoke Pharma
EVOK
$13K ﹤0.01%
+149
New +$14.8K
ZN
3503
DELISTED
Zion Oil & Gas, Inc.
ZN
$12K ﹤0.01%
+35,100
New +$19K
QCLS
3504
Q/C Technologies Inc
QCLS
$22.5M
0
BETS
3505
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
0
CHKR
3506
DELISTED
CHESAPEAKE GRANITE WASH TRUST
CHKR
$11K ﹤0.01%
+10,700
New +$13.8K
IDSA
3507
DELISTED
Industrial Services of America
IDSA
$11K ﹤0.01%
+11,200
New +$14.3K
BNTC icon
3508
Benitec Biopharma
BNTC
$431M
$10K ﹤0.01%
54
CENN icon
3509
Cenntro
CENN
$8.41M
0
SOS
3510
SOS Limited
SOS
$16.7M
$8K ﹤0.01%
+2
New +$10.3K
MTVA
3511
MetaVia Inc
MTVA
$7.54M
0
PHIO icon
3512
Phio Pharmaceuticals
PHIO
$12.7M
$6K ﹤0.01%
3
+1
+50% +$2.62K
HLTH
3513
DELISTED
Nobilis Health Corp.
HLTH
$5K ﹤0.01%
+36,364
New +$7.08K
AACG
3514
ATA Creativity
AACG
$48M
-97,200
Closed -$96K
AAT
3515
American Assets Trust
AAT
$1.41B
-34,700
Closed -$1.59M
AAXJ icon
3516
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.85B
-19,500
Closed -$1.38M
ABTS icon
3517
Abits Group
ABTS
$3.94M
-145
Closed -$9K
ACIW icon
3518
ACI Worldwide
ACIW
$5.42B
-483,933
Closed -$15.9M
ACWI icon
3519
iShares MSCI ACWI ETF
ACWI
$33.6B
-13,002
Closed -$938K
ADC icon
3520
Agree Realty
ADC
$9.34B
-48,767
Closed -$3.38M
AFMD
3521
DELISTED
Affimed
AFMD
-8,790
Closed -$369K
AGEN
3522
Agenus
AGEN
$315M
-1,702
Closed -$99K
ALB icon
3523
Albemarle
ALB
$15.4B
-29,000
Closed -$2.38M
ALT icon
3524
Altimmune
ALT
$560M
-109,306
Closed -$317K
AMAT icon
3525
Applied Materials
AMAT
$424B
-30,448
Closed -$1.21M

Similar funds

Jim Simons's Q2 2019 Portfolio in Review

As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
  • Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
  • Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
  • Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
  • Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
  • Jim Simons opened 495 new positions and closed 397 in Q2 2019.
  • Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.

Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.